United American Securities Inc. (D Moderna, Inc. Transaction History

United American Securities Inc. (D

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $207,375 - $280,927	1,750 New	1,750 $212,000
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $638,623 - $1.19 Million	-5,050 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $462,931 - $755,445	2,050 Added 68.33%	5,050 $1.28 Million
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $665,700 - $1.45 Million	3,000 New	3,000 $1.16 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of United American Securities Inc. (D, based on Form 13F filings with the SEC.

Stay updated on United American Securities Inc. (D with notifications on news.